Ticker Details
Rhythm Pharmaceuticals, Inc. Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.
IPO Date:	October 5, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$7.92B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.98 | 3.05%
Avg Daily Range (30 D):	$2.00 | 2.11%
Avg Daily Range (90 D):	$2.19 | 2.43%

Institutional Daily Volume
Avg Daily Volume:	.43M
Avg Daily Volume (30 D):	.7M
Avg Daily Volume (90 D):	.71M

Trade Size
Avg Trade Size (Sh.):	67
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	3,295
Avg Institutional Trade:	$3M
Avg Institutional Trade (30 D):	$5.96M
Avg Institutional Trade (90 D):	$4.88M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.48M
Avg Closing Trade (30 D):	$15.5M
Avg Closing Trade (90 D):	$11.44M
Avg Closing Volume:	102.86K

News

Jun 15, 2026 @ 4:51 PM Why Is Rhythm Pharma Stock Jumping Today? Source: Vandana Singh

May 29, 2026 @ 12:00 PM Rhythm Pharmaceuticals Announces Seven Abstracts A... Source: Na

May 26, 2026 @ 12:00 PM Rhythm Pharmaceuticals Announces Participation in ... Source: Rhythm Pharmaceuticals, Inc.

May 14, 2026 @ 9:25 AM Green Thumb Just Made an Unprecedented Move. Here'... Source: Keith Speights

Apr 3, 2026 @ 1:00 PM Rhythm Pharmaceuticals Announces Changes to Board ... Source: Na

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.83	$-.73	$-3.11
Diluted EPS	$-.83	$-.73	$-3.11
Revenue	$60.11M	$57.25M	$189.76M
Gross Profit	$52.96M	$52.45M	$170.27M
Net Income / Loss	$-55.64M	$-47.51M	$-196.54M
Operating Income / Loss	$-52.36M	$-47.06M	$-192.02M
Cost of Revenue	$7.16M	$4.8M	$19.49M
Net Cash Flow	$7.47M	$2.01M	$-34.87M
PE Ratio